Journal ArticleOPEN ACCESS

Evinacumab in Patients with Refractory Hypercholesterolemia

  • Rosenson R
  • Burgess L
  • Ebenbichler C
  • et al.
New England Journal of Medicine (2020) 383(24) 2307-2319
DOI: 10.1056/nejmoa2031049
260Citations
Citations of this article
171Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background Patients with refractory hypercholesterolemia, who have high low-density lipoprotein (LDL) cholesterol levels despite treatment with lipid-lowering therapies at maximum tolerate...

Cite

CITATION STYLE

APA

Rosenson, R. S., Burgess, L. J., Ebenbichler, C. F., Baum, S. J., Stroes, E. S. G., Ali, S., … Gaudet, D. (2020). Evinacumab in Patients with Refractory Hypercholesterolemia. New England Journal of Medicine, 383(24), 2307–2319. https://doi.org/10.1056/nejmoa2031049

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free